StockData
Boston Scientific Corp logo

Boston Scientific Corp (BSX) stock

BSXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 14/3048% below fair value
$43.03−0.66 (-1.51%)

Close on Nov 17, 2026Market cap $62.36BP/E 17.4Yield –

Boston Scientific revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Boston Scientific's revenue for the twelve months ending Jun 30, 2026 was $21.00B, up 13.5% year over year. For fiscal 2025 it was $20.07B, up 19.9% from the year before. Over ten years it grew 10.4% a year on average. The highest annual figure on record is $20.07B in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$20.07B+19.9%
FY2024Dec 31, 2024$16.75B+17.6%
FY2023Dec 31, 2023$14.24B+12.3%
FY2022Dec 31, 2022$12.68B+6.7%
FY2021Dec 31, 2021$11.89B+19.9%
FY2020Dec 31, 2020$9.91B-7.7%
FY2019Dec 31, 2019$10.74B+9.3%
FY2018Dec 31, 2018$9.82B+8.6%
FY2017Dec 31, 2017$9.05B+7.9%
FY2016Dec 31, 2016$8.39B+12.2%
FY2015Dec 31, 2015$7.48B+0.2%
FY2014Dec 31, 2014$7.46B+5.5%
FY2013Dec 31, 2013$7.07B+1.6%
FY2012Dec 31, 2012$6.96B-8.7%
FY2011Dec 31, 2011$7.62B-2.4%
FY2010Dec 31, 2010$7.81B-4.7%
FY2009Dec 31, 2009$8.19B+1.7%
FY2008Dec 31, 2008$8.05B-3.7%
FY2007Dec 31, 2007$8.36B–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$5.44B+7.5%
Q1 FY2026Mar 31, 2026$5.20B+11.6%
Q4 FY2025Dec 31, 2025$5.29B+15.9%
Q3 FY2025Sep 30, 2025$5.07B+20.3%
Q2 FY2025Jun 30, 2025$5.06B+22.8%
Q1 FY2025Mar 31, 2025$4.66B+20.9%
Q4 FY2024Dec 31, 2024$4.56B+22.4%
Q3 FY2024Sep 30, 2024$4.21B+19.3%
Q2 FY2024Jun 30, 2024$4.12B+14.5%
Q1 FY2024Mar 31, 2024$3.86B+13.8%
Q4 FY2023Dec 31, 2023$3.73B+14.9%
Q3 FY2023Sep 30, 2023$3.53B+11.3%
Q2 FY2023Jun 30, 2023$3.60B+10.9%
Q1 FY2023Mar 31, 2023$3.39B+12.0%
Q4 FY2022Dec 31, 2022$3.24B+3.7%
Q3 FY2022Sep 30, 2022$3.17B+8.1%
Q2 FY2022Jun 30, 2022$3.24B+5.4%
Q1 FY2022Mar 31, 2022$3.03B+10.0%
Q4 FY2021Dec 31, 2021$3.13B+15.4%
Q3 FY2021Sep 30, 2021$2.93B+10.3%
Q2 FY2021Jun 30, 2021$3.08B+53.6%
Q1 FY2021Mar 31, 2021$2.75B+8.2%
Q4 FY2020Dec 31, 2020$2.71B-6.7%
Q3 FY2020Sep 30, 2020$2.66B-1.8%
Q2 FY2020Jun 30, 2020$2.00B-23.9%
Q1 FY2020Mar 31, 2020$2.54B+2.0%
Q4 FY2019Dec 31, 2019$2.90B+13.4%
Q3 FY2019Sep 30, 2019$2.71B+13.1%
Q2 FY2019Jun 30, 2019$2.63B+5.7%
Q1 FY2019Mar 31, 2019$2.49B+4.8%
Q4 FY2018Dec 31, 2018$2.56B+6.4%
Q3 FY2018Sep 30, 2018$2.39B+7.7%
Q2 FY2018Jun 30, 2018$2.49B+10.3%
Q1 FY2018Mar 31, 2018$2.38B+10.1%
Q4 FY2017Dec 31, 2017$2.41B+11.2%
Q3 FY2017Sep 30, 2017$2.22B+6.0%
Q2 FY2017Jun 30, 2017$2.26B–
Q1 FY2017Mar 31, 2017$2.16B–
Q4 FY2016Dec 31, 2016$2.17B–
Q3 FY2016Sep 30, 2016$2.10B–

More Boston Scientific figures

See a number that looks wrong?